These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30013173)

  • 41. Dual-Sensitivity Multiple Sclerosis Lesion and CSF Segmentation for Multichannel 3T Brain MRI.
    Meier DS; Guttmann CRG; Tummala S; Moscufo N; Cavallari M; Tauhid S; Bakshi R; Weiner HL
    J Neuroimaging; 2018 Jan; 28(1):36-47. PubMed ID: 29235194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective Brain Network and Cellular Responses Upon Dimethyl Fumarate Immunomodulation in Multiple Sclerosis.
    Ciolac D; Luessi F; Gonzalez-Escamilla G; Koirala N; Riedel C; Fleischer V; Bittner S; Krämer J; Meuth SG; Muthuraman M; Groppa S
    Front Immunol; 2019; 10():1779. PubMed ID: 31417557
    [No Abstract]   [Full Text] [Related]  

  • 43. Multiparametric graph theoretical analysis reveals altered structural and functional network topology in Alzheimer's disease.
    Lin SY; Lin CP; Hsieh TJ; Lin CF; Chen SH; Chao YP; Chen YS; Hsu CC; Kuo LW
    Neuroimage Clin; 2019; 22():101680. PubMed ID: 30710870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bipolar disorders and deep grey matter in multiple sclerosis: A preliminary quantitative MRI study.
    Lorefice L; Fenu G; Carta E; Frau J; Coghe G; Contu F; Barracciu MA; Carta MG; Cocco E
    Mult Scler Relat Disord; 2020 Nov; 46():102564. PubMed ID: 33172832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Network alterations underlying anxiety symptoms in early multiple sclerosis.
    Ellwardt E; Muthuraman M; Gonzalez-Escamilla G; Chirumamilla VC; Luessi F; Bittner S; Zipp F; Groppa S; Fleischer V
    J Neuroinflammation; 2022 May; 19(1):119. PubMed ID: 35610651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Focal cortical thinning in patients with stable relapsing-remitting multiple sclerosis: cross-sectional-based novel estimation of gray matter kinetics.
    Orbach L; Menascu S; Hoffmann C; Miron S; Achiron A
    Neuroradiology; 2018 Feb; 60(2):179-187. PubMed ID: 29285552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study.
    Preziosa P; Pagani E; Mesaros S; Riccitelli GC; Dackovic J; Drulovic J; Filippi M; Rocca MA
    Hum Brain Mapp; 2017 Nov; 38(11):5648-5665. PubMed ID: 28792103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imaging as an Outcome Measure in Multiple Sclerosis.
    Ontaneda D; Fox RJ
    Neurotherapeutics; 2017 Jan; 14(1):24-34. PubMed ID: 27699722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Impact of MRI T1 Hypointense Brain Lesions on Cerebral Deep Gray Matter Volume Measures in Multiple Sclerosis.
    Buyukturkoglu K; Mormina E; De Jager PL; Riley CS; Leavitt VM
    J Neuroimaging; 2019 Jul; 29(4):458-462. PubMed ID: 30892794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disentangling brain functional network remodeling in corticobasal syndrome - A multimodal MRI study.
    Ballarini T; Albrecht F; Mueller K; Jech R; Diehl-Schmid J; Fliessbach K; Kassubek J; Lauer M; Fassbender K; Schneider A; Synofzik M; Wiltfang J; ; ; Otto M; Schroeter ML
    Neuroimage Clin; 2020; 25():102112. PubMed ID: 31821953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI.
    Battaglini M; Jenkinson M; De Stefano N;
    Hum Brain Mapp; 2018 Mar; 39(3):1063-1077. PubMed ID: 29222814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased mean R2* in the deep gray matter of multiple sclerosis patients: Have we been measuring atrophy?
    Hernández-Torres E; Wiggermann V; Machan L; Sadovnick AD; Li DKB; Traboulsee A; Hametner S; Rauscher A
    J Magn Reson Imaging; 2019 Jul; 50(1):201-208. PubMed ID: 30511803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progressive brain rich-club network disruption from clinically isolated syndrome towards multiple sclerosis.
    Shu N; Duan Y; Huang J; Ren Z; Liu Z; Dong H; Barkhof F; Li K; Liu Y
    Neuroimage Clin; 2018; 19():232-239. PubMed ID: 30035017
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gray matter network reorganization in multiple sclerosis from 7-Tesla and 3-Tesla MRI data.
    Gonzalez-Escamilla G; Ciolac D; De Santis S; Radetz A; Fleischer V; Droby A; Roebroeck A; Meuth SG; Muthuraman M; Groppa S
    Ann Clin Transl Neurol; 2020 Apr; 7(4):543-553. PubMed ID: 32255566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multi-layer analysis of quantitative 7 T magnetic resonance imaging in the cortex of multiple sclerosis patients reveals pathology associated with disability.
    Lema Dopico A; Choi S; Hua J; Li X; Harrison DM
    Mult Scler; 2021 Nov; 27(13):2040-2051. PubMed ID: 33596719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain Atrophy in Multiple Sclerosis: Clinical Relevance and Technical Aspects.
    Sastre-Garriga J; Pareto D; Rovira À
    Neuroimaging Clin N Am; 2017 May; 27(2):289-300. PubMed ID: 28391787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis.
    Sotirchos ES; Gonzalez-Caldito N; Dewey BE; Fitzgerald KC; Glaister J; Filippatou A; Ogbuokiri E; Feldman S; Kwakyi O; Risher H; Crainiceanu C; Pham DL; Van Zijl PC; Mowry EM; Reich DS; Prince JL; Calabresi PA; Saidha S
    Mult Scler; 2020 Mar; 26(3):312-321. PubMed ID: 30741108
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal Changes in Functional Brain Connectivity Predicts Conversion to Alzheimer's Disease.
    Serra L; Cercignani M; Mastropasqua C; Torso M; Spanò B; Makovac E; Viola V; Giulietti G; Marra C; Caltagirone C; Bozzali M
    J Alzheimers Dis; 2016; 51(2):377-89. PubMed ID: 26890769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: a voxel-based analysis study.
    Mallik S; Muhlert N; Samson RS; Sethi V; Wheeler-Kingshott CA; Miller DH; Chard DT
    Mult Scler; 2015 Apr; 21(4):423-32. PubMed ID: 25145689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.